Building towards a consensus for the use of tumour necrosis factor blocking agents

被引：7

作者：

Furst, DE ^{[1
]}

Breedveld, FC ^{[1
]}

Kalden, JR ^{[1
]}

Smolen, JS ^{[1
]}

机构：

[1] Univ Leiden Hosp, NL-2300 RC Leiden, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 1999年 / 58卷 / 12期

关键词：

D O I：

10.1136/ard.58.12.725

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：725 / 726

页数：2

共 20 条

[1]

ALBANI S, 1997, ARTHRITIS ALLIED CON, P979

[2]

Anderson J J, 1996, Arthritis Care Res, V9, P112, DOI 10.1002/1529-0131(199604)9:2<112::AID-ANR1790090207>3.0.CO

[3]

2-X

[4] INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].

AREND, WP ;

DAYER, JM .

ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160

[5]

BRENNAN FM, 1989, LANCET, V2, P244

[6] Anti-CD4 monoclonal antibodies in rheumatoid arthritis [J].

Choy, EHS ;

Kingsley, GH ;

Panayi, GS .

SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (1-2) :261-273

[7] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[8]

Furst DE, 1999, ANN RHEUM DIS, V58, P129

[9]

JASIN HE, 1997, ARTHRITIS ALLIED CON, P1017

[10]

Kempeni J, 1999, ANN RHEUM DIS, V58, P70

← 1 2 →